Itraconazol Medico Uno

Itraconazole, the active ingredient in Itraconazol Medico Uno, is a triazole antifungal presented as an oral formulation for systemic use. It treats a range of fungal infections, including skin, nail and deep‑tissue mycoses, and is prescribed for adult and pediatric patients when indicated.

GNH USA supplies Itraconazol Medico Uno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Itraconazole is used to treat fungal infections affecting the skin, nails, and internal organs.

- Dermatophytosis: effective treatment of superficial skin infections caused by dermatophyte fungi. - Onychomycosis: promotes clearance of fungal nail infections and improves nail appearance. - Systemic mycoses: provides therapy for invasive infections such as histoplasmosis, blastomycosis, and aspergillosis. - Candida infections: treats severe or refractory candidiasis, including bloodstream infections.

Itraconazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset. - Vomiting: occasional emesis. - Headache: mild to moderate pain. - Rash: skin redness or itching.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac failure: worsening of congestive heart failure.

When prescribing itraconazole, several safety considerations should be observed to minimize risk. - Liver function monitoring: assess baseline and periodic liver enzyme levels. - Drug interaction review: evaluate concomitant medications, especially CYP3A4 substrates and inhibitors. - Cardiac assessment: avoid use in patients with existing heart failure. - Pregnancy and lactation: prescribe only if potential benefits outweigh risks. - Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Itraconazole interacts with several medicines; awareness of the interaction level guides clinical management.

Major Interactions (Avoid): - Rifampin: induces metabolism, markedly reducing itraconazole exposure. - Ketoconazole: additive hepatotoxic potential when combined. - Macrolide antibiotics (e.g., erythromycin): increase itraconazole concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Statins (e.g., simvastatin): increased risk of myopathy due to higher statin levels. - CNS depressants: potential for enhanced sedation.